| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |